Cambridge Nutritional Sciences PLC
LSE:CNSL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cambridge Nutritional Sciences PLC
LSE:CNSL
|
UK |
|
R
|
Rimoni Industries Ltd
TASE:RIMO
|
IL |
|
H
|
Hong Kong Technology Venture Co Ltd
SWB:XHNA
|
HK |
|
V
|
Vegetable Products Ltd
BSE:539132
|
IN |
Balance Sheet
Balance Sheet Decomposition
Cambridge Nutritional Sciences PLC
Cambridge Nutritional Sciences PLC
Balance Sheet
Cambridge Nutritional Sciences PLC
| Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
6
|
2
|
5
|
3
|
5
|
|
| Cash |
6
|
2
|
5
|
3
|
5
|
|
| Short-Term Investments |
0
|
0
|
0
|
3
|
0
|
|
| Total Receivables |
4
|
3
|
2
|
2
|
2
|
|
| Accounts Receivables |
4
|
2
|
2
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
2
|
1
|
1
|
1
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
12
|
6
|
8
|
8
|
8
|
|
| PP&E Net |
5
|
1
|
1
|
1
|
1
|
|
| PP&E Gross |
0
|
1
|
1
|
1
|
1
|
|
| Accumulated Depreciation |
0
|
2
|
3
|
1
|
2
|
|
| Intangible Assets |
10
|
2
|
2
|
1
|
1
|
|
| Goodwill |
0
|
3
|
3
|
3
|
3
|
|
| Other Long-Term Assets |
3
|
6
|
1
|
1
|
1
|
|
| Other Assets |
0
|
3
|
3
|
3
|
3
|
|
| Total Assets |
30
N/A
|
18
-40%
|
14
-19%
|
14
-4%
|
14
-2%
|
|
| Liabilities | ||||||
| Accounts Payable |
3
|
0
|
1
|
1
|
3
|
|
| Accrued Liabilities |
0
|
2
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
3
|
3
|
2
|
1
|
2
|
|
| Long-Term Debt |
2
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
3
|
3
|
3
|
0
|
|
| Total Liabilities |
6
N/A
|
6
-2%
|
4
-26%
|
4
-5%
|
2
-47%
|
|
| Equity | ||||||
| Common Stock |
8
|
8
|
10
|
10
|
10
|
|
| Retained Earnings |
10
|
22
|
25
|
26
|
24
|
|
| Additional Paid In Capital |
25
|
25
|
25
|
25
|
25
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
23
N/A
|
12
-49%
|
10
-16%
|
10
-3%
|
11
+18%
|
|
| Total Liabilities & Equity |
30
N/A
|
18
-40%
|
14
-19%
|
14
-4%
|
14
-2%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
182
|
183
|
238
|
238
|
238
|
|